ERBB2 and neoplasm: Since the data in the literature supporting the above hypothesis are few and conflicting, we decided to investigate, in a group of patients from a geographical area with a low incidence of breast cancer, whether HER-2/neu positive tumours are correlated with established or suspected risk factors for breast cancer and thus to identify distinct subgroups of high risk women.